TWD
VIR icon

True Wealth Design’s Vir Biotechnology VIR Stock Holding History

True Wealth Design’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44K Buy
337
+52
+18% +$495 ﹤0.01% 1484
2026
Q1 		$2.55K Buy
285
+150
+111% +$1.2K ﹤0.01% 1441
2025
Q4 		$815 Hold
135
– – ﹤0.01% 1784
2025
Q3 		$771 Sell
135
-524
-80% -$2.68K ﹤0.01% 1846
2025
Q2 		$3.32K Buy
659
+73
+12% +$391 ﹤0.01% 976
2025
Q1 		$3.8K Buy
+586
New +$5.21K ﹤0.01% 772

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

True Wealth Design's VIR Position: Q2 2026 in Review

True Wealth Design increased its Vir Biotechnology (VIR) stake by 18% in Q2 2026, buying an estimated $495 and bringing the position to 337 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

True Wealth Design first reported a position in VIR in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.8K in Q1 2025. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • True Wealth Design held 337 shares of Vir Biotechnology worth $3.44K as of Q2 2026.
  • True Wealth Design bought 52 Vir Biotechnology shares in Q2 2026, an estimated $495.
  • Vir Biotechnology made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1484 holding.
  • True Wealth Design first reported a position in Vir Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Vir Biotechnology position peaked at $3.8K in Q1 2025.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.